The Advanced Therapies Congress is Europe’s most important advanced therapies event. The agenda, delivered by 230 global speakers to over 1,000 cell and gene specialists, focuses 12 tracks of great content, incl. cell therapy, gene editing, stem cells, and so much more!
Experts Helping You Navigate the Regulatory Challenges for Tissue Engineered Medical Products
Engage with Philadelphia’s growing cell and gene therapy ecosystem, explore promising investment and partnership opportunities, and align the latest trends and technologies with your business. Learn from experts in an interactive webcast, and network and schedule video meetings with speakers and attendees through an event app.
In this webinar on June 4th at 8:00AM PDT, learn more about the ongoing research and clinical trials to manage acute respiratory distress syndrome (ARDS) in COVID-19 patients. Two experts will share their extensive experience with therapies using mesenchymal stem cells (MSCs) and the small extracellular vesicles (sEVs) that MSCs produce as potential treatments for COVID-19 patients with ARDS.
Chardan 4th Annual Genetic Medicines Manufacturing Summit – Virtual Edition
Hear from key leaders involved in genetic medicines manufacturing, including AskBio, CureVac, MeiraGTx (MGTX), Moderna (MRNA), Prevail Therapeutics (PRVL), uniQure (QURE), and univercells. These companies will address various topics in the space.
The format for this event will be fireside chats alongside virtual manufacturing site tours and visuals of some facilities. Audience members will be able to submit questions either in advance or during presentations by emailing them to corpaccess@chardan.com.
Additionally, participating companies will be available for 1×1 meetings in the days and weeks following the summit. If you would like a 1×1 with any of the participating companies, please email corpaccess@chardan.com.
Realize the commercial potential of gene therapies.
IO360 ̊ convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 6th annual Immuno-Oncology 360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features more than 80 time sensitive IO topics, over 500 senior level thought leaders and includes over 10 hours of networking.
PARTNERING EVENT IN TOKYO – CALL FOR SPEAKERS
“Regenerative Medicine Crossroad® in Tokyo #11”
on Thursday, February 6, 2020, Tokyo, Japan
– A Can’t-miss Opportunity to Meet Your Business Partners in Japan –
We have just started the calling-for-speakers process for the eleventh edition of our Partnering Event, Regenerative Medicine Crossroad® in Tokyo (RMCR#11).
